실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
16오늘 방문
568누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-13 · 마지막 7월 13일
ADCBiologicPfizerderuxtecan improved objecti…Phase 2

Encorafenib (Encorafenib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Dynamic Tumor Resistance

#DynamicTumorResistance#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 66.7%임상시험 66상태 RECRUITING
AntibodyElevation OncologyDeruxtecan]Phase 1

CYRAMZA® (Ramucirumab, Ramucirumab (CYRAMZA®))

Stomach Neoplasm; Gastrointestinal Neoplasms · Stomach Neoplasm

#StomachNeoplasm#Antibody#Phase1#인기#항체+5
효능 ORR 44.7%임상시험 66상태 DISCONTINUED
AntibodyHoffmann-La Rochevedotin plus bendamustine a…Phase 3

Glofitamab (Glofitamab)

Diffuse Large B Cell Lymphoma (DLBCL); High Grade B Cell Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase3#인기#항체+5
임상시험 66상태 RECRUITING
ADCBiologicDaiichi SankyoDM1) and trastuzumab deruxt…Phase 3

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201)

Breast Cancer; HER2-positive Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 65.8%임상시험 66상태 RECRUITING
AntibodyTakedaPhase 2

Vedolizumab (Vedolizumab)

Ulcerative Colitis and Crohn's Disease · Colitis

#Colitis#Antibody#Phase2#인기#항체+5
효능 ORR 1%임상시험 66상태 ACTIVE
CGTBiologicJuventas Cell Therapy Ltd.Phase 2

CD19 CAR-T (CD19 CAR-T)

B-cell Malignancy; B-cell Lymphoma · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 88%임상시험 66상태 ACTIVE
ADCBiologicMerck Sharp & Dohme LLCPhase 3

Rescue medications (Rescue medications)

Lung Neoplasm Malignant · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#인기#항체약물접합체+4
임상시험 66상태 RECRUITING
ADCBiologicRemeGenvedotin plus PD-1 blockade …Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 66상태 RECRUITING
ADCBiologicPETHEMA Foundationvedotin efficacy in DLBCL w…Approved

R-CHOP (R-CHOP)

HIV Infections; Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma (DLBCL)

#DiffuseLargeBCellLymphomaDLBCL#ADC#Approved#인기#항체약물접합체+5
효능 ORR 95%임상시험 66상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCvedotin combined with pembr…Phase 2

Immune Checkpoint Inhibitor (Immune Checkpoint Inhibitor)

Unspecified Adult Solid Tumor, Protocol Specific · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 59%임상시험 66상태 RECRUITING
AntibodyShanghai Shengdi Pharmaceutical…vedotin (RC48) in combinati…Phase 2

Adebrelimab (Adebrelimab)

Pancreatic Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase2#인기#항체+5
임상시험 66상태 RECRUITING
ADCBiologicAlterome Therapeutics, Inc.sPhase 1

midazolam (midazolam)

Cancer; PDAC - Pancreatic Ductal Adenocarcinoma · Carcinomas

#Carcinomas#ADC#Phase1#인기#항체약물접합체+5
임상시험 66상태 ACTIVE
ADCBiologicAstraZenecaPhase 3

Carboplatin/Paclitaxel (Carboplatin/Paclitaxel)

Advanced Ovarian Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 75%임상시험 66상태 RECRUITING
ADCBiologicNovartis PharmaceuticalsPhase 2

Ribociclib (Ribociclib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 66.7%임상시험 66상태 RECRUITING
AntibodyAstraZenecavedotin combined with pembr…Phase 3

Durvalumab (MEDI4736, MEDI4736 (Durvalumab))

Non-Small-Cell Lung Carcinoma NSCLC · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase3#인기#항체+5
효능 ORR 36.3%임상시험 65상태 ACTIVE
ADCBiologicPfizerthatPhase 2

Gemtuzumab Ozogamicin (Gemtuzumab Ozogamicin)

Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0%임상시험 65상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCPhase 2

Corticosteroid (Corticosteroid)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 5.6%임상시험 65상태 RECRUITING
ADCBiologicHoffmann-La RochePhase 2

Xeloda (Xeloda)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 30%임상시험 65상태 RECRUITING
AntibodyAkeso-drivenPhase 2

cadonilimab (cadonilimab)

Metastatic HER2 Positive Gastroesophageal Junction Cancer · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#인기#항체+5
임상시험 65상태 RECRUITING
ADCBiologicEli Lilly and CompanyDXdPhase 1

Itraconazole (Itraconazole)

Ovarian Neoplasms; Endometrial Neoplasms · Fallopian Tube Cancer

#FallopianTubeCancer#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 10.5%임상시험 65상태 RECRUITING
ADCBiologicBristol-Myers SquibbPhase 2

6-mercaptopurine (6-mercaptopurine)

Inflammatory Bowel Disease; Ulcerative Colitis · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 22%임상시험 65상태 RECRUITING
AntibodyAmgenPhase 3

Denosumab (Denosumab)

Postmenopausal Osteoporosis · Giant Cell Tumor of Bone

#GiantCellTumorofBone#Antibody#Phase3#인기#항체+4
효능 ORR 16.7%임상시험 65상태 ACTIVE
ADCBiologicEuropean Organisation for Resea…Phase 2

Ara C (Ara C)

Lymphoma; Leukemia · CLASSICAL HODGKIN LYMPHOMA

#CLASSICALHODGKINLYMPHOMA#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 45.2%임상시험 65상태 ACTIVE
AntibodyNovartisPhase 3

Ofatumumab (Ofatumumab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Leukemia

#Leukemia#Antibody#Phase3#인기#항체+5
효능 ORR 78.4%임상시험 65상태 RECRUITING
ADCBiologicAstraZenecaPhase 3

Pemetrexed/Cisplatin (Pemetrexed/Cisplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 87.5%임상시험 64상태 RECRUITING

8 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기